Published in:
Open Access
01-12-2015 | Meeting abstract
The Vivitrol pilot program (VPP): initial quantitative findings from an extended-release naltrexone study
Authors:
Traci Rieckmann, Katherine T Garvey, Priya Srikanth, Laura Andrich, Jessica Gregg
Published in:
Addiction Science & Clinical Practice
|
Special Issue 1/2015
Login to get access
Excerpt
In 2010, the FDA approved the use of extended-release injectable naltrexone (Vivitrol©) for the treatment of opioid dependence. Preliminary evidence from prior studies indicates that monthly injections of Vivitrol are effective in treating opioid dependence after initial detoxification. This longitudinal exploratory study measures demographics, medication adherence, sobriety (urinalysis), utilization of care, and mental and emotional states in patients who were treated for opioid dependence with injectable naltrexone at an addictions stabilization center. …